Antiphospholipid, anti-β2-glycoprotein-I and anti-oxidized-low-density-lipoprotein antibodies in antiphospholipid syndrome

QJM: An International Journal of Medicine

Volumn 91, Issue 9, 1998, Pages 619-626

  Cuadrado, M J ^a   Tinahones, F ^b   Camps, M T ^b   De Ramon, E ^b   Gomez Zumaquero J M ^b   Mujic, F ^c   Khamashta, M A ^c   Hughes, G R V ^c  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; LOW DENSITY LIPOPROTEIN; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ADULT; AGED; ANTIGEN SPECIFICITY; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RECURRENT DISEASE; REGRESSION ANALYSIS; SPONTANEOUS ABORTION; STATISTICAL ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; THROMBOSIS;

EID: 0031756021     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Hughes GRV. Thrombosis, abortion, cerebral disease and the lupus anticoagulant. Br Med J 1983; 287:1088-9.
2. Harris EN, Gharavi AE, Boey ML et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; ii:1211-14.
3. Harris EN, Chan JK, Asherson RA, Aber VA, Charavi AE, Hughes GRV. Thrombosis, recurrent fetal loss and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Arch Inetrn Med 1986; 146:2153-6.
4. Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus and related disorders. Ann Intern Med 1990; 112:682-98.
5. Matsuura E, Igarashi Y, Fujimoto M, Ichicawa K, Koike T. Anticardiolipin cofactor(s) and the differential diagnosis of autoimmune disease. Lancet 1990; 336:177-8.
6. Galli M, Cornfurius P, Maassen C, et al. Anticardiolipin antibodies directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990; 335:1544-7.
7. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA. Antiphospholipid antibodies are directed against a complex antigen includes a lipid-binding inhibitor of coagulation: b2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990; 87:4120-4.
8. Bevers EM, Galli M, Barbui T, Comfurius P, Zwaal RFA. Lupus anticoagulant IgG's (LA) are not directed to phospholipid only, but to a complex of lipid-bound human prothrombin. Thromb Haemost 1991; 66:629-32.
9. Permpikul P, Rao LVM, Rapaport SI. Functional and binding studies of the roles of prothrombin and β2-glycoprotein I in the expression of lupus anticoagulant activity. Blood 1994; 83:2878-92.
10. Blank M, Cohen J, Toder V, Shoenfeld Y. Induction of antiphospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc Natl Acad Sci USA 1991; 88:3069-73.
11. Branch DW, Dudley DJ, Mitchell MD. IgC fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: a model for autoimmune fetal loss. Am J Obstet Gynecol 1990; 163:210-16.
12. Pierangeli SS, Liu XW, Barker JH, Anderson G, Harris EN. Induction of thrombosis in a mouse model by IgG, IgM and IgA immunoglobulins from patients with the antiphospholipid syndrome. Thromb Haemost 1995; 74:1361-7.
13. Pierangeli SS, Liu XW, Anderson G, Barker JH, Harris EN. Thrombogenic properties of murine anti-cardiolipin antibodies induced by β2-glycoprotein I and human immunoglobulin C antiphospholipid antibodies. Circulation 1996; 94:1746-51.
14. Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet 1994; 344:793-5.
15. Salonen JT, Chiesa R, Milissano C, Mäutläri M, Manninen V. Autoantibody against oxidized LDL and progression of carotid atherosclerosis. Lancet 1992; 339:883-7.
16. Maggi E, Chiesa R, Milissano C, et al. LDL oxidation in patients with severe carotid atherosclerosis. A study in vitro and in vivo oxidation markers. Arthrioscler Thromb 1994; 14:1892-9.
17. 7. Puurunen M, Mänttäri M, Manninen V, et al. Antibody against oxidized low-density lipoprotein predicting myocardial infarction. Arch Intern Med 1994; 154:2605-9.
18. Parums DV, Brown DL, Mitchinson MJ. Serum antibodies to oxidized low density lipoprotein and ceroid in human periaortitis. Arch Pathol Lab Med 1990; 114:383-7.
19. Harris EN, Baguley E, Asherson RA, Hughes CRV. Clinical and serological features of the antiphospholipid syndrome (APS). Br J Rheumatol 1987; 26: 19 (abstract).
20. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthrits Rheum 1982; 25:1271-7.
21. Special report from the National Institute of Neurological Disorders and Stroke: classification of cerebrovascular diseases III. Stroke 1990; 21:637-76.
22. Harris EN, Gharavi AE, Patel SP, Hughes GRV. Evaluation of the anticardiolipin antibody test: Report of an international workshop held 4th April 1986. Clin Exp Immunol 1987; 60:215-22.
23. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of anticoagulants: an update. Thromb Haemost 1995; 74:1185-90.
24. Radack KL, Ronan G, Hedges J. The likehood ratio: an improved meassure for reporting and evaluating diagnostic test results. Arch Pathol Lab Med 1986; 110:689-93.
25. Sammaritano LR, Ng S, Sobel R, et al. Anticardiolipin IgG subclasses: association of IgG2 with arterial and/or venous thrombosis. Arthritis Rheum 1997; 40:1998-2006
26. D'Angelo A, Safa O, Cripp L, et al. relationship of lupus anticoagulant, anticardiolipin antibodies, anti-β2 glycoprotein I and anti-prothrombin autoantibodies with history of thrombosis in patients with the clinical suspicion of APA-syndrome. Thromb Haemost 1997; 78:967-8.
27. Amengual O, Atsumi T, Khamashta MA, Tinahones F, Hughes GRV. Autoantibodies against oxidised low-density lipoprotein in antiphospholipid syndrome. Br J Rheumatol 1997; 36:964-8
28. Vaarala O, Mänttäri M, Manninen V, et al. Anticardiolipin antibodies and risk of myocardial infarction in a prospective cohort of midle-aged men. Circulation 1995; 91:23-7.
29. Vaarala O, Alfthan G, Jauhiainen M, Lerisalo-Repo M, Aho K, Palosuo T. Crossreaction between antibodies to oxidized lipoprotein and to cardiolipin in systemic lupus erythematosus. Lancet 1993; 341:923-5.
30. Vaarala O, Lerisalo-Repo M, Aho K, et al. Affinity-purified cardiolipin-binding antibodies show heterogeneity in their binding to oxidized low-density lipoprotein. Clin Exp Immunol 1996; 104:269-74.
31. Miller GJ. Lipoproteins and the haemostatic system in atherothrombotic disorders. Baillieres Clin Haematol 1994; 7:713-32.
32. Rosove MH, Brewer PMC. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 1992; 117:303-8.
33. Khamashta MA, Cuadrado MJ, Mujic F, Taub N, Hunt BJ, Hughes GRV. Management of thrombosis in the antiphospholipid antibody syndrome. N Engl J Med 1995; 332:993-7.
34. Puurunen M, Vaarala O, Julkunen H, Aho K, Palosuo T. Antibodies to phospholipid-binding plasma proteins and occurrence of thrombosis in patients with systemic lupus erythematosus. Clin Immunol Immunopathol 1996; 80:16-22.
35. Tsutsumi A, Matsuura E, Ichikawa K, et al. Antibodies to β2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus. Arthritis Rheum 1996; 39:1466-74.
36. Finazzi G, Brancaccio V, Moia M, et al. Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian registry. Am J Med 1996; 100:350-6.
37. McCrae KR. Antiphospholipid antibody associated thrombosis: A consesus for treatment?. Lupus 1996; 5:560-70.
38. Ginsberg JS, Wells PS, Brill-Edwards P, et al. Antiphospholipid antibodies and venous thromboembolism. Blood 1995; 86:3685-91.
39. Barbui T, Radici E, Cortelazzo S, et al. Antiphospholipid antibodies in early repeated abortions: A case-controlled study. Fertil Steril 1988; 50:589-92.
40. Maier DB, Parke A. Subclinical autoimmunity in recurrent aborters. Fertil Steril 1989; 51:280-5.
41. Unander AM, Norberg R, Hahn L, Arfors L. Anticardiolipin antibodies and complement in ninety-nine women with habitual abortion. Am J Obstet Gynecol 1987; 156:114-19.
42. Parke AL, Wilson D, Maier D. The prevalence of antiphospholipid antibodies in women with recurrent spontaneous abortion, women with successful pregnancy, and women who have never been pregnant. Arthritis Rheum 1991; 34:1231-5.
43. Cowchock S, Smith JB, Gocial B. Antibodies to phospholipids and nuclear antigens in patients with repeated abortions. Am J Obstet Gynecol 1986; 155:1002-10.
44. Petri M, Golbus M, Anderson R, Whiting-O'Keefe Q, Corash L, Hellman D. Antinuclear antibody, lupus anticoagulant, and anticardiolipin antibody in women with idiopathic habitual abortion. A controlled prospective study of forty-four women. Arthritis Rheum 1987; 30:601-6.
45. Lockshin M, Druzin ML, Goei S, et al. Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Engl J Med 1985; 313:152-6.
46. Lockshin MD, Qamar T, Druzin ML, et al. Antibody to cardiolipin, lupus anticoagulant, and fetal death. J Rheumatol 1987; 14:259-63.
47. Alarcon-Segovia D, Deleze M, Oria CV, et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus: A prospective analysis of 500 consecutive patients. Medicine 1989; 68:353-61.
48. Lockwood CJ, Romero R, Feinberg RF, et al. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. Am J Obstet Gynecol 1989; 161:369-75.
49. Pattison NS, Chamley LW, McKay EJ, et al. Antiphospholipid antibodies in pregnancy: Prevalence and clinical associations. Br J Obstet Gynaecol 1993; 100:190-6.
50. Lynch A, Marlar R, Murphy J, et al. Antiphospholipid antibodies in predicting adverse pregnancy outcome. Ann Intern Med 1994; 120:470-7.
51. Triplett DA, Brandt JT, Musgrave KA, Orr CA. The relationship between lupus anticoagulants and antibodies to phospholipid. JAMA 1988; 259:550-4.
52. Rix P, Stentoft J, Aunsholt Niels-Aage, et al. Lupus anticoagulant and anticardiolipin antibodies in an obstetric population. Acta Obstet Gynecol Scand 1992; 71:605-9.
53. Aoki K, Dudkiewicz AB, Matsuura E, Novoty M, Kaberlein G, Gleicher N. Clinical significance of β2 CPI dependent anticardiolipin antibodies in the reproductive autoimmune failure syndrome: correlation with conventional antiphospholipid antibody detection systems. Am J Obstet Gynecol 1995; 172:926-32.
54. Ogasawara M, Aoki K, Matsuura E, Sasa H and Yagami Y. Anti-β2 GPI antibodies and lupus anticoagulant in patients with recurrent pregnancy loss. Prevalence and clinical significance. Lupus 1996; 5:587-92.